A combination of ingredients may cause potentially life-threatening electrical malfunctions in the heart.
Industry analysts expect the price for the single-treatment therapy to be anywhere from $1.5 million to $5 million.
Government shutdown 2019
Is the tech IPO resurgence at risk?
After World War II, tobacco companies found blacks slightly preferred menthol more than whites; decades of marketing followed.
Regulatory changes would face a process that could take years and face litigation.
They warn the usage of e-cigarettes by teens has reached an epidemic proportion.
The Food and Drug Administration is trying to help mitigate the shortage of EpiPens, those auto-injecting devices used to treat allergic reactions to things like peanuts and bee stings. It’s extended by four months the expiration date for some EpiPen…
Will this be the catalyst for big pharmaceutical companies to get into the pot business?
More patients who are terminally ill will potentially have access to experimental drugs under a measure passed by the House last night. President Donald Trump is expected to sign the so-called “right-to-try” bill. Forty states have already passed similar legislation.…
The FDA plans to unveil a website today naming pharmaceutical companies that have blocked the development of generic drugs by failing to provide samples to competitors. This public posting is part of FDA Commissioner Scott Gottlieb’s larger crackdown to, as…